Evidence map›Paper›PMID 25762750›Full record

SynthesisNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2015

Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Andrea H Weinberger, Philip H Smith, Sharon S Allen, Kelly P Cosgrove, Michael E Saladin, Kevin M Gray, Carolyn M Mazure, Cora Lee Wetherington, Sherry A McKee

Registry-linked trialOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05515354 (Coordinating Smoking Cessation Treatment With Menstrual Cycle Phase to Improve Quit Outcomes), which is not on this map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05515354 phase4recruitingnot on this mapstarted 2022, after this paper: background citation

Coordinating Smoking Cessation Treatment With Menstrual Cycle Phase to Improve Quit Outcomes: A Randomized Controlled Trial

TypeinterventionalSponsorCentre for Addiction and Mental HealthRan2022 to 2026Enrolled1,200ConditionsNicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use DisorderArmsTiming of nicotine replacement therapy start date, Nicotine Replacement Therapy Agent
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. The Influence of Perimenstrual Daily Ovarian Hormones on Anxiety and Cigarette Craving.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  12. Smoking Cessation in Black Adults: Differences by Sex and Age.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  13. Article
  14. Difficulties with emotion regulation amplify perimenstrual emotional distress and cigarette craving.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2025
    Article
  15. Review
  16. Article
  17. Effects of Ovarian Hormone Levels on Stress, Cigarette Craving, and Smoking in a Laboratory Relapse Paradigm Among Females Who Smoke Daily.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Andrea H Weinbergerandrea.weinberger@einstein.yu.edu.
Philip H SmithDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT;
Sharon S AllenWomen's Health Research at Yale, Yale University School of Medicine, New Haven, CT;
Kelly P CosgroveDepartment of Family Medicine and Community Health, Medical School, University of Minnesota, Minneapolis, MN;
Michael E SaladinDepartments of Psychiatry, Diagnostic Radiology, and Neurobiology, Yale University School of Medicine, New Haven, CT;
Kevin M GrayDepartments of Health Sciences and Research and Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC;
Carolyn M MazureDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT; Women's Health Research at Yale, Yale University School of Medicine, New Haven, CT;
Cora Lee WetheringtonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC;
Sherry A McKeeDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT;
Yale University · USMedical University of South Carolina · USUniversity of Minnesota Medical Center · USYeshiva University · US

Funding

Vocational Training for Drug Dependent WomenP50DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2002 to 2017
$14.5M
Yale SCOR on Gender-Sensitive Treatment for Tobacco DependenceP50DA033945 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2012 to 2017
$6.5M
Statistical Analysis CoreP50DA033942 · NIDA · UNIVERSITY OF MINNESOTA · PI CARROLL, MARILYN E. · 2012 to 2017
$6.3M
TOBACCO CESSATION IN POSTMENOPAUSAL WOMENR01DA008075 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ALLEN, SHARON S · 1993 to 2016
$5.5M
Imaging Genetics in Tobacco SmokersK02DA031750 · NIDA · YALE UNIVERSITY · PI COSGROVE, KELLY P. · 2012 to 2016
$634k
Progesterone and Postpartum Relapse to SmokingR21DA034840 · NIDA · UNIVERSITY OF MINNESOTA · PI ALLEN, SHARON S · 2013 to 2014
$418k
NIDA NIH HHS K02-DA031750NIDA NIH HHS P50 DA016511NIDA NIH HHS P50-DA016511NIDA NIH HHS P50-DA033942NIDA NIH HHS P50 DA033945NIDA NIH HHS P50-DA033945NIDA NIH HHS R01-DA008075NIDA NIH HHS R21-DA034840
6 · The paper itself

Abstract

introductionTo determine the effect of ovarian hormones on smoking, we conducted a systematic review of menstrual cycle effects on smoking (i.e., ad lib smoking, smoking topography, and subjective effects) and cessation-related behaviors (i.e., cessation, withdrawal, tonic craving, and cue-induced craving).

methodsThirty-six papers were identified on MEDLINE that included a menstrual-related search term (e.g., menstrual cycle, ovarian hormones), a smoking-related search term (e.g., smoking, nicotine), and met all inclusion criteria. Thirty-two studies examined menstrual phase, 1 study measured hormone levels, and 3 studies administered progesterone.

resultsSufficient data were available to conduct meta-analyses for only 2 of the 7 variables: withdrawal and tonic craving. Women reported greater withdrawal during the luteal phase than during the follicular phase, and there was a nonsignificant trend for greater tonic craving in the luteal phase. Progesterone administration was associated with decreased positive and increased negative subjective effects of nicotine. Studies of menstrual phase effects on the other outcome variables were either small in number or yielded mixed outcomes.

conclusionsThe impact of menstrual cycle phase on smoking behavior and cessation is complicated, and insufficient research is available upon which to conduct meta-analyses on most smoking outcomes. Future progress will require collecting ovarian hormone levels to more precisely quantify the impact of dynamic changes in hormone levels through the cycle on smoking behavior. Clarifying the relationship between hormones and smoking-particularly related to quitting, relapse, and medication response-could determine the best type and timing of interventions to improve quit rates for women.

Indexed as

Menstrual CycleAdultFemaleFollicular PhaseGender IdentityHumansLuteal PhaseSmokingSmoking CessationSubstance Withdrawal SyndromeWomen's Health

Identifiers

PMID25762750
PMCPMC4429881
OpenAlexW2152880682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.